As Abbvie Common Stock (ABBV) Share Value Rose, Financial Engines Advisors Has Upped by $1.51 Million Its Position; As Sherwin (SHW) Market Value Rose, Carderock Capital Management Has Raised Its Holding

November 15, 2017 - By Adrian Mccoy

Carderock Capital Management Inc increased its stake in Sherwin (SHW) by 117.66% based on its latest 2017Q2 regulatory filing with the SEC. Carderock Capital Management Inc bought 3,365 shares as the company’s stock rose 6.75% with the market. The institutional investor held 6,225 shares of the building materials company at the end of 2017Q2, valued at $2.19 million, up from 2,860 at the end of the previous reported quarter. Carderock Capital Management Inc who had been investing in Sherwin for a number of months, seems to be bullish on the $36.06 billion market cap company. The stock declined 0.92% or $3.59 reaching $385.58 on the news. About 45,505 shares traded. Sherwin-Williams Co (NYSE:SHW) has risen 15.27% since November 15, 2016 and is uptrending. It has underperformed by 1.43% the S&P500.

Financial Engines Advisors Llc increased its stake in Abbvie Common Stock (ABBV) by 9.51% based on its latest 2017Q2 regulatory filing with the SEC. Financial Engines Advisors Llc bought 21,039 shares as the company’s stock rose 6.17% with the market. The institutional investor held 242,367 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $17.57 million, up from 221,328 at the end of the previous reported quarter. Financial Engines Advisors Llc who had been investing in Abbvie Common Stock for a number of months, seems to be bullish on the $148.71 billion market cap company. The stock declined 1.52% or $1.44 reaching $93.29 on the news. About 901,698 shares traded. AbbVie Inc (NYSE:ABBV) has risen 10.63% since November 15, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.

Financial Engines Advisors Llc, which manages about $88.20 billion and $2.17 billion US Long portfolio, decreased its stake in Wgl Hldgs Inc (NYSE:WGL) by 4,952 shares to 22,240 shares, valued at $1.86 million in 2017Q2, according to the filing.

Investors sentiment increased to 1 in 2017 Q2. Its up 0.01, from 0.99 in 2017Q1. It increased, as 55 investors sold ABBV shares while 581 reduced holdings. 138 funds opened positions while 500 raised stakes. 1.04 billion shares or 0.53% more from 1.04 billion shares in 2017Q1 were reported. Smith Moore And has 0.66% invested in AbbVie Inc (NYSE:ABBV) for 27,247 shares. 19,000 are held by Fundx Investment Group Ltd. Strategic Advsrs Limited Liability Co holds 46,529 shares or 1.54% of its portfolio. 3,335 are owned by Cypress Capital Mgmt Lc (Wy). Strategy Asset Managers Ltd Co has 24,587 shares. Supplemental Annuity Collective Of Nj reported 19,849 shares. Salient Trust Lta has 0.34% invested in AbbVie Inc (NYSE:ABBV). The New Jersey-based Princeton Port Strategies Limited Com has invested 2.44% in AbbVie Inc (NYSE:ABBV). Godshalk Welsh Capital has invested 0.65% in AbbVie Inc (NYSE:ABBV). World Asset Management Incorporated holds 0.4% or 160,098 shares in its portfolio. Parsec Financial Mgmt Inc reported 0.03% stake. Silvercrest Asset Group Inc Limited owns 225,911 shares. Mason Street Advsrs Ltd holds 220,888 shares. Cadinha And Lc has invested 0.3% in AbbVie Inc (NYSE:ABBV). Janney Montgomery Scott Lc accumulated 536,912 shares.

Since May 18, 2017, it had 0 insider buys, and 2 insider sales for $8.79 million activity. GONZALEZ RICHARD A also sold $4.67 million worth of AbbVie Inc (NYSE:ABBV) on Friday, May 19. ALBAN CARLOS also sold $3.21M worth of AbbVie Inc (NYSE:ABBV) on Wednesday, June 14. CHASE WILLIAM J sold $2.50 million worth of stock or 38,300 shares.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 66 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Monday, July 17. The firm earned “Buy” rating on Sunday, October 29 by SunTrust. The firm has “Buy” rating given on Monday, March 7 by Goldman Sachs. As per Wednesday, October 11, the company rating was maintained by BMO Capital Markets. The rating was downgraded by Barclays Capital to “Equal-Weight” on Tuesday, December 1. The stock has “Buy” rating by SunTrust on Monday, October 16. The stock of AbbVie Inc (NYSE:ABBV) earned “Market Perform” rating by BMO Capital Markets on Friday, June 10. On Monday, November 28 the stock rating was downgraded by Citigroup to “Neutral”. On Monday, June 6 the stock rating was downgraded by Cowen & Co to “Market Perform”. The rating was upgraded by Leerink Swann to “Outperform” on Monday, October 2.

More notable recent AbbVie Inc (NYSE:ABBV) news were published by: Investorplace.com which released: “AbbVie Inc (ABBV) Earnings: 12 Things to Know” on October 27, 2017, also Nasdaq.com with their article: “Can AbbVie (ABBV) Spring a Surprise this Earnings Season?” published on October 24, 2017, Seekingalpha.com published: “AbbVie: Another Spectacular Quarter From This Dividend Aristocrat” on October 28, 2017. More interesting news about AbbVie Inc (NYSE:ABBV) were released by: Nasdaq.com and their article: “Physicians Financial Services, Inc. Buys DowDuPont Inc, Red Hat Inc, AbbVie …” published on November 02, 2017 as well as Nasdaq.com‘s news article titled: “Tiaa Cref Investment Management Llc Buys DowDuPont Inc, Costco Wholesale Corp …” with publication date: November 13, 2017.

Carderock Capital Management Inc, which manages about $350.61M and $221.66 million US Long portfolio, decreased its stake in Acuity Brands Inc (NYSE:AYI) by 3,872 shares to 7,505 shares, valued at $1.53 million in 2017Q2, according to the filing. It also reduced its holding in Intuit (NASDAQ:INTU) by 5,701 shares in the quarter, leaving it with 35,165 shares, and cut its stake in Ansys (NASDAQ:ANSS).

More notable recent Sherwin-Williams Co (NYSE:SHW) news were published by: Investorplace.com which released: “Sherwin Williams (SHW) a Buy on Strong Quant Score” on October 27, 2017, also Nasdaq.com with their article: “Sherwin-Williams Company (SHW) Ex-Dividend Date Scheduled for November 16, 2017” published on November 15, 2017, Nasdaq.com published: “Sherwin-Williams Co Bottom Line Declines 18% In Q3” on October 24, 2017. More interesting news about Sherwin-Williams Co (NYSE:SHW) were released by: Investorplace.com and their article: “Sherwin Williams (SHW) a Buy on Robust Sales Growth” published on November 03, 2017 as well as Seekingalpha.com‘s news article titled: “Dividend Aristocrats In Focus Part 12: Sherwin-Williams” with publication date: October 17, 2017.

Among 25 analysts covering Sherwin-Williams Company (NYSE:SHW), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Sherwin-Williams Company had 50 analyst reports since July 22, 2015 according to SRatingsIntel. The company was maintained on Friday, September 1 by KeyBanc Capital Markets. The stock of Sherwin-Williams Co (NYSE:SHW) earned “Sector Weight” rating by KeyBanc Capital Markets on Monday, March 21. The firm earned “Neutral” rating on Wednesday, October 25 by UBS. The firm has “Overweight” rating given on Tuesday, April 4 by KeyBanc Capital Markets. As per Wednesday, March 16, the company rating was upgraded by Longbow. Barclays Capital maintained it with “Equal Weight” rating and $295.0 target in Monday, November 2 report. KeyBanc Capital Markets maintained Sherwin-Williams Co (NYSE:SHW) on Wednesday, October 4 with “Overweight” rating. The stock of Sherwin-Williams Co (NYSE:SHW) has “Neutral” rating given on Tuesday, August 25 by Sterne Agee CRT. The firm has “Overweight” rating by Atlantic Securities given on Tuesday, November 29. RBC Capital Markets maintained Sherwin-Williams Co (NYSE:SHW) on Monday, August 14 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.